Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ACP-104
DRUG
2 trials
Sponsors
ACADIA Pharmaceuticals Inc.
, University of Texas Southwestern Medical Center
Conditions
Schizophrenia
Phase 1
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
Completed
NCT00628420
University of Texas Southwestern Medical Center
Schizophrenia
Start: 2005-01-31
End: 2007-10-31
Updated: 2011-06-28
Phase 2
ACP-104 in Acutely Psychotic Subjects With Schizophrenia
Completed
NCT00490516
ACADIA Pharmaceuticals Inc.
Schizophrenia
Start: 2007-06-30
End: 2008-02-29
Updated: 2025-01-20